Completed PHASE3 INTERVENTIONAL 2-arm
NCT07418957
Efficacy and Safety of Vaginal Lactobacillus Dual Probiotic Capsules in Bacterial Vaginosis (BV)
Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Clinical Study on the Efficacy and Safety of Vaginal Lactobacillus Dual Probiotic Capsules for the Treatment of Bacterial Vaginosis
Sponsor: Guangdong Longchuangji Pharmaceutical Co., Ltd.
Conditions
Bacterial Vaginosis (BV)
Interventions
Placebo Vaginal Lactobacillus Dual Probiotic Capsules
Updated 1 time since 2026 Last updated: Feb 11, 2026 Started: Jun 12, 2024 Primary completion: May 17, 2025 Completion: Jul 3, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
Listed as NCT07418957, this PHASE3 trial focuses on Bacterial Vaginosis (BV) and remains completed. Sponsored by Guangdong Longchuangji Pharmaceutical Co., Ltd., it has been updated 1 time since 2024, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Status Flow
Change History
1 version recorded Completed — PHASE3
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Guangdong Longchuangji Pharmaceutical Co., Ltd.
Data source: Guangdong Longchuangji Pharmaceutical Co., Ltd.
For direct contact, visit the study record on ClinicalTrials.gov .